Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes

Immunotherapy is a promising advancement in the treatment of non-small-cell lung carcinoma (NSCLC), although much of how lung tumors interact with the immune system in the natural course of disease remains unknown. We investigated the impact of the expression of immune-centric genes and pathways in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Carcinogenesis
Autors principals: Watza, Donovan, Lusk, Christine M, Dyson, Gregory, Purrington, Kristen S, Chen, Kang, Wenzlaff, Angela S, Ratliff, Valerie, Neslund-Dudas, Christine, Bepler, Gerold, Schwartz, Ann G
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Cancer Biomarkers and Molecular Epidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314333/
https://ncbi.nlm.nih.gov/pubmed/30202894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgy119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars